The effect of suramin on B16F10 melanoma lung colonies and M5076 retic
ulosarcoma liver metastasis formation was evaluated in C57B1/6 female
mice. Single i.v. doses of 200 mg/kg suramin given 48 and 24 h prior t
o tumor cell injection significantly inhibited metastasis formation in
both models, whereas the same treatment administered 24 h after cell
injection was ineffective. A dose-response experiment in the B16F10 me
lanoma model showed that inhibition of lung colony formation was still
significant with 50 mg/kg pretreatment, whereas a borderline effect w
as observed at 10 mg/kg. At the effective doses, the plasma and organ
concentrations of suramin were far below those needed to exert signifi
cant in vitro cytotoxic or cytostatic effects on B16F10 and M5076 cell
s. Thus, in addition to the antineoplastic effect of suramin our resul
ts indicate a potential antimetastatic role for this compound.